ROVI
|
Laboratorios Farmaceuticos ROVI
|
0.02%
|
ES
|
MC
|
ROCK
|
Gibraltar Industries, Inc.
|
0.02%
|
US
|
NASDAQ
|
ROAD
|
Construction Partners, Inc.
|
0.02%
|
US
|
NASDAQ
|
RNST
|
Renasant Corporation
|
0.02%
|
US
|
NASDAQ
|
RDWR
|
Radware Ltd.
|
0.02%
|
US
|
NASDAQ
|
RCKT
|
Rocket Pharmaceuticals, Inc.
|
0.02%
|
US
|
NASDAQ
|
RAMP
|
LiveRamp Holdings, Inc.
|
0.02%
|
US
|
NYSE
|
QURE
|
uniQure N.V.
|
0.02%
|
US
|
NASDAQ
|
PYCR
|
Paycor HCM, Inc.
|
0.02%
|
US
|
NASDAQ
|
PRTA
|
Prothena Corporation plc
|
0.02%
|
US
|
NASDAQ
|
PROX
|
Proximus NV
|
0.02%
|
BE
|
BR
|
PRAA
|
Portfolio Recovery Associates, Inc.
|
0.02%
|
US
|
NASDAQ
|
PLUS
|
ePlus inc.
|
0.02%
|
US
|
NASDAQ
|
PLAB
|
Photronics, Inc.
|
0.02%
|
US
|
NASDAQ
|
PHP
|
Primary Health Properties Plc
|
0.02%
|
UK
|
LSE
|
PHAT
|
Phathom Pharmaceuticals, Inc.
|
0.02%
|
US
|
NASDAQ
|
PFC
|
Petrofac Limited
|
0.02%
|
UK
|
LSE
|
PDFS
|
PDF Solutions, Inc.
|
0.02%
|
US
|
NASDAQ
|
PCRX
|
Pacira Pharmaceuticals, Inc.
|
0.02%
|
US
|
NASDAQ
|
PCOR
|
Procore Technologies, Inc.
|
0.02%
|
US
|
NYSE
|